Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Kallmann syndrome (KS) is an uncommon genetic disorder characterized by isolated congenital hypogonadotropic hypogonadism (CHH) and anosmia/hyposmia. KS originates from abnormal embryonic migration of olfactory axons and gonadotropin-releasing hormone (GnRH)-synthesizing neurons. It can be challenging to diagnose due to its heterogeneous clinical presentation and genes implied. Herein, we report a rare phenotype of KS in two sisters accompanied by a variety of nonreproductive disorders such as hypoparathyroidism, hypercortisolism, atrophy of the cerebellum, intellectual disability, and remarkably, ovarian dysgenesis. Additionally, both subjects present muscle weakness, exercise intolerance, marked hypotonia and seizures, being suspected, although not fully confirmed, mitochondrial encephalomyopathy. These cases illustrate the heterogeneous clinical presentation and the diagnostic difficulties often found in patients suffering from this condition. These clinical features have never been described before as associated with KS; therefore, we decided to report this novel KS phenotype.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537203 | PMC |
| http://dx.doi.org/10.1007/s43032-022-00897-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Lysine at Position 177 Is Essential to Limit the Inhibitory Capacities of Sprouty4 Protein in Normal and Cancer-Derived Cells.
Int J Mol Sci
July 2025
Center for Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1190 Vienna, Austria.
The Sprouty (Spry) proteins modulate signalling and regulate processes like cellular migration and proliferation. Here, we investigated a Spry4 alteration substituting a lysine at position 177 to an arginine, based on a mutation found in Kallmann syndrome, a genetically heterogeneous disease connected to reduced fibroblast growth factor receptor1 (FGFR) signalling. Using growth curves to evaluate proliferative and scratch assays to determine migrative capacities of the cells, in normal fibroblasts as well as in osteosarcoma-derived cells, we demonstrate that the modified Spry4 version hinders both processes, which the unaltered protein cannot do under the same conditions.
View Article and Find Full Text PDFTherapeutic effects of a pulsatile GnRH pump on adult male patients with congenital hypogonadotropic hypogonadism (CHH): a retrospective study.
Transl Androl Urol
July 2025
Department of Urology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Background: Traditional treatments for congenital hypogonadotropic hypogonadism (CHH) primarily focus on human chorionic gonadotropin (hCG) monotherapy, combined gonadotrophin treatment or Testosterone replacement therapy, which has certain limitations in effectiveness. In recent years, pulsatile gonadotropin-releasing hormone (GnRH) pump treatment, capable of mimicking physiological hormone release patterns, has become a more preferred treatment option. However, there is still a scarcity of medium- and long-term studies in this regard.
View Article and Find Full Text PDFSpatiotemporal regulation by downstream genes of in the olfactory system: from development to function.
Front Cell Dev Biol
July 2025
The Airway Mucus Institute, Yonsei University College of Medicine Seoul, Seoul, Republic of Korea.
Introduction: Olfaction is important for the quality of life; however, in Kallmann syndrome (KS), defective development results in olfactory dysfunction. Notably, the mechanism underlying olfactory development, especially in the olfactory epithelium (OE), which detects olfactory signals, remains unclear. Mutations in PROK2, which encodes prokineticin-2, have been identified in approximately 9% of the KS patients with olfactory defects.
View Article and Find Full Text PDFSpontaneous Improvement of Hypogonadotropic Hypogonadism in a Patient with and Mutations: A Case Report.
Life (Basel)
July 2025
Division of Endocrinology, Loma Linda University Health Consortium, Loma Linda, CA 92354, USA.
Kallmann syndrome (KS) is a form of hypogonadotropic hypogonadism (HH) characterized by gonadotropin-releasing hormone (GnRH) deficiency and anosmia due to defective neuronal migration. While traditionally considered irreversible, cases of spontaneous improvement of HH have been reported, suggesting residual GnRH neuronal function in some individuals. We present a case of a 29-year-old man with KS who exhibited spontaneous recovery of endogenous testosterone production following the cessation of long-term androgen therapy without the use of alternative hormonal agents.
View Article and Find Full Text PDFAltered glucose metabolism in default mode network and prefrontal circuit in patients with Kallmann syndrome.
EJNMMI Res
July 2025
Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, Hunan Province, 410013, China.
Background: This study delineates brain metabolic signatures underlying neuroendocrine-psychosocial interactions in Kallmann syndrome (KS), a rare genetic disorder characterized by congenital hypogonadism and anosmia. In this prospective case-control study, 30 KS patients and 30 matched healthy controls (HCs) underwent brain [F]FDG PET scans, sex hormone assays, and standardized neuropsychological assessments. A voxel-wise group comparison analysis was conducted to identify clusters of brain metabolic patterns between KS patients and HCs.
View Article and Find Full Text PDF